Genomics BioSci & Tech. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	138.3	172.58	253.03	317	107.5
Short-Term Investments	34.6	65	-	-	-
Cash & Short-Term Investments	172.9	237.58	253.03	317	107.5
Cash Growth	-27.23%	-6.11%	-20.18%	194.90%	-81.30%
Accounts Receivable	183.71	138.86	116.1	100.02	81.75
Other Receivables	0.44	0.39	0.74	0.01	1.44
Receivables	184.15	139.25	116.84	100.02	83.2
Inventory	235.82	185.49	61.51	54.8	20.99
Prepaid Expenses	14.11	18.09	16.85	8.83	21.92
Other Current Assets	32.39	34.77	23.58	17.45	18.23
Total Current Assets	639.36	615.19	471.82	498.1	251.83
Property, Plant & Equipment	648.09	648.43	498.69	373.37	311.02
Long-Term Investments	99.79	74.65	153.98	237.96	285.83
Other Intangible Assets	6.54	5.77	1.73	0.86	1.16
Long-Term Accounts Receivable	-	0.64	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	0.07
Other Long-Term Assets	32.34	15.68	7.63	9.44	3.27
Total Assets	1,426	1,360	1,134	1,120	853.18
Accounts Payable	125.67	97.4	29.73	40.47	27.31
Accrued Expenses	42.54	35.4	28.7	34.5	27.54
Short-Term Debt	250.11	128.96	50	50	-
Current Portion of Long-Term Debt	60.87	35.41	4.86	12.4	3.9
Current Portion of Leases	6.5	6.43	6.51	4.75	3.39
Current Income Taxes Payable	-	-	-	0.58	-
Current Unearned Revenue	33.44	43.69	12.72	20	18.89
Other Current Liabilities	14.18	35.48	13.57	6.21	13.57
Total Current Liabilities	533.3	382.77	146.09	168.91	94.59
Long-Term Debt	301.47	328.89	214.01	153.35	75.67
Long-Term Leases	9.3	7.98	8.24	8.34	3.58
Total Liabilities	844.07	719.64	368.33	330.6	173.84
Common Stock	724.48	724.48	724.48	630.28	578.92
Additional Paid-In Capital	1.07	30.15	131.53	58.91	43.76
Retained Earnings	-213.33	-204.06	-88.24	101.85	36.07
Comprehensive Income & Other	-1.87	-1.84	-2.25	-1.91	20.59
Total Common Equity	510.34	548.73	765.51	789.13	679.34
Minority Interest	71.72	91.99	-	-	-
Shareholders' Equity	582.07	640.73	765.51	789.13	679.34
Total Liabilities & Equity	1,426	1,360	1,134	1,120	853.18
Total Debt	628.25	507.67	283.61	228.84	86.53
Net Cash (Debt)	-455.35	-270.08	-30.58	88.17	20.96
Net Cash Growth	-	-	-	320.57%	-95.42%
Net Cash Per Share	-6.29	-3.73	-0.43	1.39	0.35
Filing Date Shares Outstanding	72.45	72.45	72.45	64.29	60.23
Total Common Shares Outstanding	72.45	72.45	72.45	64.29	60.23
Working Capital	106.06	232.42	325.73	329.19	157.24
Book Value Per Share	7.04	7.57	10.57	12.27	11.28
Tangible Book Value	503.8	542.96	763.78	788.27	678.18
Tangible Book Value Per Share	6.95	7.49	10.54	12.26	11.26
Land	206.74	206.74	139.79	104.76	104.76
Buildings	266.04	256.36	211.33	144.63	134.61
Machinery	315.59	234.39	231.91	142.81	150.45
Construction In Progress	-	52.59	0.23	79.45	26.25
Leasehold Improvements	1.01	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.